Using Big Data For CER Will Be Harder Than Safety Studies – PCORI Investigator Platt
Richard Platt of PCORI’s National Patient-Centered Clinical Research Network discusses the future of comparative effectiveness research using big data during an expert roundtable session hosted by NEHI.
You may also be interested in...
Manufacturers, payers and providers will need to learn how to trust each other’s data sources if the benefits of the big datasets of real-world evidence are to be realized, pharmaceutical execs say.
FDA’s Janet Woodcock used her time at a conference on biomedical innovation to highlight ways to use FDA’s Sentinel network more broadly to standardize, and hopefully streamline comparative effectiveness research.
Data from the pilot program a “driving factor” in the agency’s decision against changing its recommendations for the blood thinner following reports of increased serious bleeding events.